Related Experiment Video

Updated: Jul 4, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Smad7 as a therapeutic agent for chronic kidney diseases

Hui Yao Lan1

  • 1Department of Medicine, The University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong. hylan@hku.hk <hylan@hku.hk>

Frontiers in Bioscience : a Journal and Virtual Library
|May 30, 2008
PubMed

Insights

Smad7 gene therapy effectively inhibits kidney fibrosis and inflammation in chronic kidney disease models. This approach targets the transforming growth factor-beta (TGF-beta) signaling pathway, offering a promising therapeutic strategy.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Transforming growth factor-beta 1 (TGF-beta1) is implicated in renal fibrosis by increasing extracellular matrix (ECM) production.
  • TGF-beta1 signaling involves receptor-associated Smads (Smad2/3) promoting fibrosis and inhibitory Smads (Smad7) counteracting it.
  • Smad7 also exhibits anti-inflammatory properties by inhibiting the NF-kappaB pathway.

Purpose of the Study:

  • To investigate the therapeutic potential of Smad7 in inhibiting renal fibrosis and inflammation.
  • To elucidate the mechanisms by which Smad7 exerts its effects in chronic kidney disease models.

Main Methods:

  • Gene transfer of Smad7 was employed in experimental models of chronic kidney diseases.
  • Experimental models included obstructive nephropathy, remnant kidney disease, and autoimmune crescentic glomerulonephritis.
  • Mechanisms investigated included blockade of Smad2/3 activation and inhibition of the NF-kappaB pathway.

Main Results:

  • Gene transfer of Smad7 significantly inhibited renal fibrosis across multiple experimental models.
  • Overexpression of Smad7 blocked Smad2/3 activation, a key mechanism for reducing renal scarring.
  • Smad7 demonstrated anti-inflammatory effects by inhibiting the NF-kappaB-dependent inflammatory pathway.

Conclusions:

  • Smad7 plays a dual role in combating both renal fibrosis and inflammation in chronic kidney diseases.
  • Targeting the TGF-beta/Smad signaling pathway through Smad7 overexpression presents a novel therapeutic avenue for chronic kidney diseases.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...